Enteric fever imported to the Czech Republic: epidemiology, clinical characteristics and antimicrobial susceptibility
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
- MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální léková rezistence MeSH
- břišní tyfus epidemiologie mikrobiologie MeSH
- cestování MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- mladiství MeSH
- mladý dospělý MeSH
- paratyfus epidemiologie mikrobiologie MeSH
- retrospektivní studie MeSH
- Salmonella enterica klasifikace účinky léků genetika izolace a purifikace MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Asie MeSH
- Česká republika epidemiologie MeSH
- Egypt MeSH
- Mexiko MeSH
- Názvy látek
- antibakteriální látky MeSH
The aim of this study was to describe epidemiological and clinical characteristics of imported enteric fever in Czech travellers and to determine the antimicrobial susceptibility of isolated strains. Retrospective descriptive study included adult patients treated with enteric fever at Hospital Na Bulovce during January 2004-December 2012. A case of typhoid or paratyphoid fever was defined as isolation of Salmonella Typhi or Paratyphi from blood or stool. During the study period, there have been diagnosed 19 cases of enteric fever (12 males and 7 females) with age median of 30 years; 14 cases were caused by Salmonella Typhi and 5 cases by S. Paratyphi A. The infection has been acquired in South Asia (16 patients; 84.2 %), in Africa (Egypt, Angola) in two cases (10.5 %), and in Mexico (1; 5.3 %). Symptoms included fever (all patients), diarrhoea (16 cases; 84.2 %), headache (9; 47.4 %), and abdominal pain (7; 36.8 %). Seventeen patients (89.5 %) were treated with fluoroquinolones; however, the treatment failure was observed in seven of them (41.2 %). Decreased ciprofloxacin susceptibility was detected in eight strains (66.7 %), and one strain (8.3 %) was multidrug resistant. Sequence analysis of quinolone resistance-determining regions (QRDR) of the gyrA gene revealed the presence of amino acid substitutions in all tested isolates with decreased ciprofloxacin susceptibility. Typhoid and paratyphoid fevers represent epidemiologically important diseases that may lead to potentially life-threatening complications. Major issue in the management of enteric fever represents the non-susceptibility of Salmonella strains to fluoroquinolones and other antimicrobials.
Zobrazit více v PubMed
BMJ. 2006 Jul 8;333(7558):78-82 PubMed
J Travel Med. 2001 Nov-Dec;8(6):293-7 PubMed
Am J Trop Med Hyg. 2010 Jun;82(6):1121-6 PubMed
J Antimicrob Chemother. 1996 May;37(5):891-900 PubMed
J Travel Med. 2013 Jan-Feb;20(1):17-21 PubMed
Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1295-301 PubMed
Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):963-70 PubMed
J Travel Med. 1995 Sep 1;2(3):165-168 PubMed
J Antimicrob Chemother. 2006 Dec;58(6):1139-44 PubMed
JAMA. 2000 May 24-31;283(20):2668-73 PubMed
J Infect. 2010 Feb;60(2):91-8 PubMed
Lancet Infect Dis. 2005 Oct;5(10):623-8 PubMed
Bull World Health Organ. 2004 May;82(5):346-53 PubMed
J Travel Med. 2005 Sep-Oct;12(5):275-81 PubMed
Vaccine. 2006 May 1;24(18):3804-11 PubMed
Antimicrob Agents Chemother. 1999 Sep;43(9):2131-7 PubMed
Lancet. 2005 Aug 27-Sep 2;366(9487):749-62 PubMed
Clin Infect Dis. 2003 Jul 1;37(1):75-81 PubMed
Arch Intern Med. 1998 Mar 23;158(6):633-8 PubMed
Clin Infect Dis. 2012 Oct;55(8):1107-13 PubMed
Clin Infect Dis. 2010 Jan 15;50(2):241-6 PubMed
Postgrad Med J. 2000 Feb;76(892):80-4 PubMed
Travel Med Infect Dis. 2011 Jul;9(4):206-12 PubMed
